Can-Fite BioPharma American Depositary Shares
CANF
5 hedge funds and large institutions have $854K invested in Can-Fite BioPharma American Depositary Shares in 2015 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 5 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
20% more capital invested
Capital invested by funds: $710K → $854K (+$144K)
0% more ownership
Funds ownership: 0% → 0% (+0%)
50% less funds holding
Funds holding: 10 → 5 (-5)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TAM
Taylor Asset Management
Toronto,
Ontario, Canada
|
+$770K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ES
Equitec Specialists
Chicago,
Illinois
|
-$265K |
| 2 |
Renaissance Technologies
New York
|
-$190K |
| 3 |
VKH
Virtu KCG Holdings
New York
|
-$70K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$23K |
| 5 |
Goldman Sachs
New York
|
-$23K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
TAM
1
Taylor Asset Management
Toronto,
Ontario, Canada
| $763K | +$770K | +110 | +1,833% |
|
|
VKH
2
Virtu KCG Holdings
New York
| $48K | -$70K | -10 | -59% |
|
|
MC
3
Menta Capital
San Francisco,
California
| $27K | – | – | – |
|
|
4
UBS Group
Zurich,
Switzerland
| $11K | +$7K | +1 | +100% |
|
|
MFS
5
MSI Financial Services
Springfield,
Massachusetts
| $4K | – | – | – |
|
|
TRCT
6
Tower Research Capital (TRC)
New York
| $1K | – | – | – |
|
|
ES
7
Equitec Specialists
Chicago,
Illinois
| – | -$265K | -40 | Closed |
|
|
8
Renaissance Technologies
New York
| – | -$190K | -28 | Closed |
|
|
9
Citadel Advisors
Miami,
Florida
| – | -$23K | -3 | Closed |
|
|
10
Goldman Sachs
New York
| – | -$23K | -3 | Closed |
|
11
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| – | -$16K | -2 | Closed |
|
CANF Hedge Fund Activity: Q2 2015 in Review
5 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in Can-Fite BioPharma American Depositary Shares (CANF) for Q2 2015, worth a combined $854K — up 20% from $710K a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of CANF and 0 opened new positions — a net loss of 5 holders — while 1 trimmed existing stakes and 2 added.
The largest buyer was Taylor Asset Management, adding an estimated $770K. The largest seller was Equitec Specialists, exiting entirely with an estimated $265K sold.
- 5 institutional investors held Can-Fite BioPharma American Depositary Shares (CANF) as of Q2 2015, down from 10 in Q1 2015.
- Funds reported $854K of Can-Fite BioPharma American Depositary Shares stock for Q2 2015, up 20% quarter-over-quarter.
- 0 funds opened new Can-Fite BioPharma American Depositary Shares positions in Q2 2015 and 5 closed out, a net change of -5 holders.
- The largest Can-Fite BioPharma American Depositary Shares buyer in Q2 2015 was Taylor Asset Management, an estimated $770K added.
- The largest Can-Fite BioPharma American Depositary Shares seller in Q2 2015 was Equitec Specialists, an estimated $265K sold.
Based on aggregated 13F filings for Q2 2015.